SCHEMBL9830453

SCHEMBL9830453

FC1CC=CC=N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4480868 0.69
SCHEMBL20389168 0.69
SCHEMBL19202494 0.69
SCHEMBL14445008 0.69
SCHEMBL7265383 0.69
SCHEMBL8266084 0.69
SCHEMBL1679515 0.69
SCHEMBL3601925 0.69
SCHEMBL13674570 0.69
SCHEMBL3123334 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3891154-B1 5-HYDROXY-7-OXABICYCLO[2.2.1]HEPTANE-2-CARBOXAMIDE DERIVATIVES FOR INDUCING CHONDROGENESIS FOR TREATING JOINT DAMAGE NOVARTIS AG (CH) 2023-08-16 EP disclosed
EP-2966065-A2 HYDROXYLATED AND METHOXYLATED CYCLOPENTA [D] PYRIMIDINES AS AKT PROTEIN KINASE INHIBITORS Array Biopharma, Inc. (US) 2016-01-13 EP disclosed
EP-2399909-B1 Hydroxylated cyclopenta[d]pyrimidines as AKT protein kinase inhibitors ARRAY BIOPHARMA INC (US) 2015-08-26 EP disclosed
EP-2402325-B1 Hydroxylated cyclopenta[d]pyrimidines as AKT protein kinase inhibitors ARRAY BIOPHARMA INC (US) 2015-08-26 EP disclosed
EP-0163238-B1 SUBSTITUTED AND BRIDGED PYRIDINES USEFUL AS PHARMACEUTICAL AGENTS MERCK & CO. INC. (US) 1991-07-24 EP disclosed
US-4579851-A HYPOTENSIVE, ANTIARRHYTHMIA AGENTS MERCK & CO., INC. (US) 1986-04-01 US disclosed
EP-0163238-A2 Substituted and bridged pyridines useful as pharmaceutical agents MERCK & CO. INC. (US) 1985-12-04 EP disclosed